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Abstract
The first lineage decision during mouse development is the establishment of trophectoderm and inner cell mass lineages, morphologically
distinguishable at the blastocyst stage. The Caudal-like transcription factor Cdx2 is required for repression of inner cell mass genes Oct4 and Nanog
in the trophectoderm. Expression of Cdx2 in the trophectoderm is thus one of the earliest known events in lineage determination. However, it is not
clear whether the Cdx2 expression pattern is the cause or the consequence of this first lineage decision. Here, we show that Cdx2 is initially
ubiquitously expressed, and becomes progressively upregulated in outside, future trophectoderm cells prior to blastocyst formation. Ubiquitous
Cdx2 expression begins around the time of cell polarization, but we show that cell polarization is independent of zygotic Cdx2. Finally, we show
functionally that Cdx2 is downstream of lineage allocation since Cdx2 mutant cells, which show cell-autonomous defects in expression of Oct4,
Nanog, and the trophectoderm marker Eomesodermin, do not preferentially contribute to inner cell mass in chimeric blastocysts. Cdx2 therefore
appears to act downstream of the first lineage decision, suggesting that processes influencing lineage allocation or morphogenesis may regulate
Cdx2 expression along the inside/outside axis of the embryo.
© 2007 Elsevier Inc. All rights reserved.Keywords: Preimplantation; Tbr2; aPKC; Troma; EndoA; Krt8; Lineage specification; Morula; TrophoblastIntroduction
The first lineage decision during mouse development is the
establishment trophectoderm (future placenta) and inner cell mass
(future embryo and other extraembryonic tissues) prior to
implantation. Self-renewing trophoblast and embryonic stem
cell lines have been derived from each of these lineages (Evans
and Kaufman, 1981; Martin, 1981; Ralston and Rossant, 2005;
Tanaka et al., 1998), suggesting that insight into the molecular
mechanisms underlying the first lineage decision will extend our
understanding of stem cell biology and regulation of pluripotency.
However, the molecular mechanisms underlying the allocation of⁎ Corresponding author. Program in Developmental and Stem Cell Biology,
Hospital for Sick Children Research Institute, MARS Building, TorontoMedical
Discovery Tower, 101 College St., Toronto, ON, Canada M5G 1L7. Fax: +1 416
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doi:10.1016/j.ydbio.2007.10.054initially totipotent cells of the embryo to either trophectoderm
or inner cell mass lineages are not fully understood.
Unlike other species whose early embryonic patterning relies
on maternally deposited spatial information, the early mouse
embryo appears to rely on spatial information arising from to-
pological changes in cell position. Cell polarization established
during the 8-cell stage, and maintained in the trophectoderm
lineage, has been proposed to contribute to determining cell
position within the embryo, and thus lineage specification
(Johnson et al., 1981). More recently, the importance of lineage-
specific transcription factors in lineage segregation has been
highlighted by studies both in the embryo and in stem cell lines
(reviewed in Yamanaka et al., 2006). The transcription factor
Cdx2 is thought to play a key role since its restricted expression
in the trophectoderm is required to repress initially ubiquitous
inner cell mass genes Oct4 (Pou5f1) and Nanog (Strumpf et al.,
2005). Moreover, overexpression of Cdx2 can cause embryonic
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al., 2005; Tolkunova et al., 2006), suggesting that Cdx2 acts
early in the lineage-determining hierarchy.
While both cell polarization and transcription factor-based
mechanisms are important for early lineage specification, the
connection between these two processes is less clear. For ex-
ample, it is unknown whether Cdx2 expression in the trophec-
toderm arises as a consequence of pre-existing spatial informa-
tion in the embryo or whether Cdx2 imparts spatial information
to the embryo. Understanding the link between lineage-specific
transcription factors such as Cdx2 and morphological position
within the embryo will help us understand how cell fate and
morphogenesis are connected during early mouse development.
In this study we show evidence that Cdx2 is initially ubi-
quitously expressed, but becomes progressively upregulated in
outside cells prior to blastocyst formation. We show that while
the timing of Cdx2 expression and cell polarization are similar,
Cdx2 is genetically downstream of cell polarization. Cdx2 mu-
tant trophectoderm cells exhibit defects in expression of tro-
phectoderm markers, such as Keratin8 (Krt8, EndoA) and
Eomesodermin (Eomes), in addition to ectopic inner cell mass
markers (Strumpf et al., 2005). In spite of these molecular
changes, however, Cdx2 mutant cells are still able to contribute
at normal frequency to trophectoderm tissue in chimeric em-
bryos. Cell fate markers are cell-autonomously misregulated in
these cells, arguing against rescue by neighboring wild type
trophectoderm. We propose a model in which factors upstream
of Cdx2 regulate cell polarity and epithelialization of outer cells.
Subsequent expression of Cdx2 within these cells confers
trophectoderm fate upon the protoepithelium through regulation
of lineage-specific target genes.
Materials and methods
Embryo collection
Embryos were collected at appropriate time points from timed natural
matings. Preimplantation embryos were collected by flushing dissected oviducts
or uteri with M2 medium (Specialty Media, Chemicon). Postimplantation em-
bryos were dissected from decidua on embryonic day 4.5 (E4.5) or E6.5 in PBS
with Ca2+ and Mg2+. Reichert’s membranes were removed from E6.5 embryos
prior to fixation. Embryos were fixed immediately without culture, unless
otherwise indicated. Mice used in this study included wild type (strain ICR),
Cdx2tm1Fbe, a null allele of Cdx2 (Chawengsaksophak et al., 1997), and B5/
EGFP, in which Enchanced Green Fluorescent Protein (EGFP) is ubiquitously
expressed (Hadjantonakis et al., 1998). All lines were maintained on an ICR
background.
Embryo and cell genotyping
Cdx2 null embryos, and Cdx2 null cells within chimeras, were identified by
immunofluorescent staining of Cdx2, as previously established (Strumpf et al.,
2005).
Immunofluorescent staining
Immediately after harvesting, embryos were fixed in 4% formaldehyde
(Polysciences) in PBS (with Ca2+ and Mg2+) for 10 min at room temperature.
Embryos were then permeabilized with 0.5% Triton X-100 in PBS for 15–
30 min at room temperature, then blocked in PBS+0.1% Triton X-100+10%
Fetal Calf Serum for at least 1 h at room temperature or overnight at 4 °C.Embryos were incubated with primary antibodies in blocking solution overnight
at 4 °C. Embryos were then transferred to blocking solution for at least 30 min at
room temperature, and then incubated in secondary antibody in blocking
solution for 1 h at room temperature. Finally, embryos were transferred to
blocking solution containing nuclear stain and incubated several hours at room
temperature or overnight at 4 °C. Primary antibodies included: mouse anti-Cdx2
(1:200, CDX-88, Biogenex), rat anti-Endo-A (1:10, Troma-1, Developmental
Studies Hybridoma Bank, University of Iowa), rabbit anti-PKCζ (1:400, C-20,
Santa Cruz), rabbit anti-Tbr2 (Eomes) (1:100, Dr. Mark Hevner and Chemicon),
rabbit anti-Nanog (1:200, Cosmo Bio), mouse anti-Oct4 (1:10, C-10, Santa
Cruz), rabbit anti-Cdx2 (1:200) (Chawengsaksophak et al., 1997), and rabbit
anti-GFP (1:100, Invitrogen). Secondary antibodies included Cy3, Cy5, or
Alexa488-conjugated goat anti-mouse, goat anti-rat, and goat anti-rabbit (1:400,
Jackson and Molecular Probes). Nuclear stains included Yoyo-1 (1:400,
Molecular Probes)+400 μg/mL RNAse, and DRAQ5 (1:400, Alexis Biochem-
icals). Mouse anti-Cdx2 was used for all experiments, except those in involving
co-staining with mouse anti-Oct4, in which rabbit anti-Cdx2 was used. In
negative control experiments, a subset of embryos at each time point were
stained with secondary antibody and nuclear stain only and imaged in parallel to
control embryos.
Confocal microscopy and image analyses
Images were collected using a Zeiss LSM 510 Meta laser scanning confocal
microscope. Analysis of Cdx2 expression levels, Krt8, and aPKC localization
were collected using a 40× water-immersion objective, and serial optical
sections were collected at 5 μm intervals. Settings remained constant for each
embryo imaged within a given session to allow direct comparison of expression
levels among embryos stained in the same batch. To score Cdx2 expression
patterns, it was sometimes necessary to adjust imaging program contrast levels
to allow visualization of extremely weak staining. In this case, however, levels
were adjusted identically for all optical sections. Similar adjustment of negative
control images (stained with secondary antibody only) failed to reveal equi-
valent signal. Other images presented in this study were collected using 25× or
40× water-immersion objectives, 5 μm sections, and confocal settings were
unchanged during the confocal session. For comparison of levels between
mutant and non-mutant embryos, images collected at similar focal planes were
compared.
Estimation of Cdx2 levels
To estimate Cdx2 and DRAQ5 levels, we measured average pixel intensity
in cross section using ImageJ software. Cdx2 values were divided by corres-
ponding DRAQ5 value to obtain a DRAQ5-normalized Cdx2 value. Contribu-
tion of cells to outside or inside populations at 16- and 32-cell stages was
determined by visual examination of cell position, inferred from z-series images
of Draq5 and membrane-localized aPKC staining. Cells that were entirely
enclosed by other cells were defined as inside cells. Normalized values of three
embryos for each cell population at each stage were determined and logarith-
mically transformed to produce data sets of similar variance. A one-way
ANOVA test (α level 0.05) of log-transformed values detected a significant
difference among the groups (pb0.001), and a post-hoc Tukey test was per-
formed to assess significance of differences between all groups (Statistica 7.0).
Generation of chimeric embryos
Two-cell embryos were collected from intercrosses between B5/EGFP and
ICR mice or Cdx2 heterozygotes early in the morning on embryonic day 1.5
(E1.5). Zonae pellucidae were removed by brief incubation of embryos in acidic
Tyrode’s solution (Sigma) at room temperature, followed by several washes in
KSOM (Specialty Media, Chemicon). Blastomeres were dissociated in regular
or Ca2+-free KSOM (Nagy, 2003). Single EGFP-expressing blastomeres were
aggregated with single blastomeres from embryos of Cdx2 mutant litters in
depression wells in KSOM droplets under light mineral oil. Chimeric embryos
were cultured for 72 h, and then fixed for immunofluorescent staining. In some
experiments, EGFP was visualized directly, while in others the signal was
boosted using an anti-GFP antibody (see above). The statistical significance of
differences among cell populations was tested by one-way ANOVA.
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Timing and localization of zygotic Cdx2 expression
Around the blastocyst stage, high levels of Cdx2 are
restricted to the trophectoderm (Beck et al., 1995; Strumpf et
al., 2005), but mechanisms leading to the establishment of this
pattern are not known. Interestingly, Cdx2 protein and mRNA
has been detected as early as the 8-cell stage (Niwa et al., 2005;
Strumpf et al., 2005), which precedes establishment of distinct
inside and outside cell populations. Since cells of the 8-cell
embryo will give rise to both inner cell mass and trophectoderm
(Fleming, 1987), Cdx2 must be repressed as cells are allocated
to inner cell mass. However, the timing of changes in Cdx2
levels between inside and outside cell populations has not been
carefully examined.
To characterize the dynamics of Cdx2 expression during
establishment of inside and outside populations, we performed a
detailed time course of Cdx2 expression by immunofluorescent
localization. We used confocal laser microscopy to generate a z-
series for each embryo to provide complete three-dimensional
information. We also used the nuclear marker DRAQ5 to label
nuclei so that the exact cell number could be determined for
each embryo. We were unable to detect Cdx2 protein in nuclei
of 2-cell (n=20, Fig. 1A) or 4-cell embryos (n=7, Fig. 1B),
even with greatly boosted confocal settings. Using these set-
tings, similar levels of fluorescence were detected in 2-cell
embryos stained with secondary antibody only (n=3, Supple-
mental Figure 1A), and only slightly weaker cytoplasmic stain-
ing was observed in control 4-cell embryos stained with se-
condary antibody only (n=2, Supplemental Figure 1B).
From 8- to 32-cell stages, nuclear Cdx2 was detectable, but
the pattern was variable, even among cells of embryos of the
same cell number. Cdx2 expression patterns comprised three
general categories: ubiquitous (detectable in all nuclei), mosaic
(detectable in some nuclei), and undetectable (detectable in no
nuclei) (Figs. 1C–G). Among embryos with detectable Cdx2,
levels appeared to differ among nuclei, and this is discussed
further in the next section. Embryos that contained cells in me-
taphase were excluded from this analysis, since Cdx2 was never
nuclear in these cells. From the 8-cell stage to midway between
16- and 32-cell stages, we observed a progressive decrease in
the proportion of embryos with undetectable or mosaic Cdx2,
and an increase in the proportion of embryos with ubiquitous
Cdx2 (Fig. 1G), suggesting that ubiquitous Cdx2 expression is
initiated during a broad developmental window. However, after
this window, the proportion of mosaic embryos increased,
presumably representing emergence of the blastocyst pattern of
Cdx2 expression. Importantly, we failed to detect nuclear signal
in littermates stained only with secondary antibody using
identical confocal settings during the same confocal session
(n=7; Figs. 1H, I and Supplemental Figure 1C).
To investigate patterning of Cdx2 further, we looked for
evidence that mosaic Cdx2 was patterned across the inside/
outside axis of embryos during these early stages. Around the
32-cell stage, cells with undetectable Cdx2 were always located
inside the embryo (11 of 11 embryos), consistent with theeventual pattern of Cdx2 expression in the blastocyst. However,
prior to this stage, the correlation was less clear. At the 16-cell
stage, cells with undetectable Cdx2 were observed among
outside cells (6 of 13 mosaic embryos), and no obvious inside/
outside topology exists at the 8-cell stage. Thus while mosaic
Cdx2 expression around the 32-cell stage correlates with inside/
outside position within the embryo, early Cdx2 mosaicism is
likely due to variable onset of initial gene expression. In support
of this hypothesis, we also noted a correlation in the apparent
onset of Cdx2 expression and developmental stage among 8-
cell embryos. That is, Cdx2 was not detectable in most un-
compacted 8-cell embryos (13 of 15 uncompacted 8-cell
embryos), whereas Cdx2 was detectable in most compacted 8-
cell embryos (11 of 15 compacted 8-cell embryos). This trend
was also evidenced among mosaic embryos, since we observed
a progressive increase in the proportion of nuclei with detect-
able Cdx2 from eight to 32-cell stages (Table 1). These observ-
ations strongly suggest that Cdx2 is expressed in all cells ini-
tially, and must therefore be downregulated or repressed in
inside cells during blastocyst formation.
Changes in Cdx2 levels during establishment of inside and
outside populations
Our observations suggested that Cdx2 is initially ubiquitous,
in terms of absolute “on/off” expression of Cdx2. However, this
analysis disregarded subtle differences in expression levels that
might be patterned across the inside/outside axis of the embryo
prior to blastocyst formation. We next compared levels of Cdx2
expression in embryos at 8-, 16-, and 32-cell stages by exam-
ining projected z-series images collected from embryos of
different stages during the same confocal session. This method
revealed an apparent increase in levels of nuclear Cdx2 from 8-
cell to 32-cell stages (Figs. 2A–C). Interestingly, Cdx2 levels in
presumptive inside cells at 16- and 32-cell stages appeared to be
higher than levels seen in cells at the 8-cell stage. While com-
pelling, however, this analysis does not provide precise quan-
titative or spatial information.
To more precisely examine expression levels in inside and
outside cells, we therefore developed a method to calculate
nuclear Cdx2 levels that takes into account changes in signal
intensity due to changes in depth of focal plane. Using image
analysis software, we measured the average, cross-sectional
pixel value for the nuclear stain DRAQ5. This analysis revealed
a progressive decline in signal with increasing depth of focal
plane in all embryos examined, regardless of cell number (n=16
embryos, not shown). We therefore used these values to norm-
alize Cdx2 levels measured in the same way. We examined
average normalized Cdx2 levels during establishment of inside
and outside populations in a group of embryos imaged during
the same confocal session (n=3, each stage). By the 16-cell
stage, average Cdx2 levels in inside cells had increased by
almost two-fold compared to 8-cell levels. In outside cells of the
16-cell embryo, levels had increased by about three-fold,
compared with 8-cell levels. By the 32-cell stage, Cdx2 levels in
inside cells remained two-fold higher than 8-cell levels, but
average levels in outside cells had increased to four times 8-cell
Fig. 1. Cdx2 expression during preimplantation development. (A) Confocal cross-section of a representative 2-cell embryo showing Cdx2 and Cdx2 merged with a
nuclear stain (colors indicated). (B) Cross-section of a representative 4-cell embryo. (C) Cross-section of a mosaic 8-cell embryo showing nuclear Cdx2 in two nuclei
(arrowheads), but not in the third nucleus visible in this section (asterisk). (D) Cross-section of a mosaic 16-cell embryo showing nuclei with and without (asterisk)
detectable Cdx2. (E) Cross-section of a 32-cell embryo with ubiquitous nuclear Cdx2. Of the nuclei visible in this section, all have detectable, if different, levels of
Cdx2. Location of the polar body (pb), a transient extraembryonic structure, is indicated. (F) Cross-section of a 30-cell mosaic blastocyst with trophectoderm (TE)-
expressed Cdx2. Note weak, but detectable Cdx2 in some cells within the inner cell mass (ICM, arrowhead). (G) Chart summarizing percent of embryos at indicated
stages comprising three general expression pattern categories: ubiquitous (nuclear Cdx2 detectable in all cells of the embryo, regardless of relative levels), mosaic
(nuclear Cdx2 detectable in some nuclei of the embryo, regardless of cell position within the embryo), and undetectable (nuclear Cdx2 not detectable in any nucleus,
regardless of image analysis settings). Total number of embryos examined at each stage is indicated (n). Rare embryos captured between 8- and 16-cell stages are
summarized in the 9–15 cell category. Embryos with developmentally arrested blastomeres were not included in this study. (H) Cross-section of a 16-cell embryo
stained with secondary antibody and Draq5 only showing the level of background signal. (I) Cross section of a 31-cell embryo stained with secondary antibody and
Draq5 only. Control images were collected during the same confocal session and with the same settings as used for corresponding embryos shown in previous
panels.
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detected across the inside/outside axis as early as the 16-cell
stage, and this difference is enhanced at the 32-cell stage by
elevation of Cdx2 expression in outside cells.Cell polarization precedes and is independent of zygotic Cdx2
Cdx2 expression begins around the 8-cell stage, which is
around the same stage that cells begin to polarize along the
Table 1
Average number of nuclei with detectable Cdx2 among mosaic embryos
8-cell stage 16-cell stage 32-cell stage
Number of mosaic embryos 9 13 3
Average number of Cdx2-positive
cells per embryo
5.9±0.8 14±1 29±1
Average percent positive per embryo 73±9.7% 88±8.8% 90±3.6%
Among embryos with mosaic Cdx2 expression, the number of Cdx2-positive
nuclei were counted. Average values for each stage appear with associated (+/−)
standard deviations.
618 A. Ralston, J. Rossant / Developmental Biology 313 (2008) 614–629inside/outside (apical/basal) axis (reviewed in Johnson and
McConnell, 2004). Although numerous proteins become differ-
entially distributed at this stage, the atypical protein kinase CFig. 2. Changes in Cdx2 levels during development. (A) Projected confocal z-serie
embryo. (B) Projected z-series showing Cdx2 and DRAQ5 in a 16-cell embryo coll
presence of cells with apparently lower Cdx2 levels. (C) Projected z-series showing C
in panels A and B. (D) Comparison of average Draq5-normalized nuclear Cdx2 leve
same cell number were imaged during the same confocal session and with identical co
groups were significantly different (pb0.001) with the exception of inside cells at 1isoform ζ (aPKC) is thought to play an early, possibly causal,
role in apical cell polarization in the early mouse embryo (Plusa
et al., 2005; Yamanaka et al., 2006). Apically localized aPKC
has been observed during preimplantation development (Pau-
ken and Capco, 2000; Plusa et al., 2005), but the timing of its
localization with respect to changes in Cdx2 expression has not
been examined.
At the 4-cell stage, aPKC did not appear polarized (n=7; Fig.
3A), but faint apical aPKC was detected in most embryos at the
8-cell stage (Figs. 3B, E). These observations, consistent with a
previous report (Plusa et al., 2005), suggest that a shift from
apolar to apical aPKC occurs during the 8-cell stage. Inter-
estingly, at 16- and 32-cell stages, aPKC became localized to thes showing extremely weak Cdx2 and the nuclear marker DRAQ5 in an 8-cell
ected during same confocal session as the embryo shown in panel A. Note the
dx2 and DRAQ5 in a 32-cell embryo, collected during same session as embryos
ls within indicated cell populations. For each stage, three embryos of about the
nfocal settings. Error bars represent standard deviations of normalized values. All
6- and 32-cell stages.
Fig. 3. Cdx2 activity is downstream of cell polarization. (A) Confocal cross-section of a representative 4-cell embryo showing apolar aPKC. (B) Representative 8-cell
embryo showing apically localized aPKC (asterisks) and merged aPKC and nuclear stain. (C) Representative 16-cell embryo with membrane-localized aPKC; note
presence of membrane-localized aPKC in inside cells (arrowhead). (D) Representative 32-cell embryo with aPKC localized to the membrane of outside and inside
(arrowhead) cells. (E) Summary of changes in aPKC localization during indicated stages. (F) Confocal cross-section of aPKC localization in a non-mutant blastocyst
(E3.5) from Cdx2 heterozygous intercross. Note elevated aPKC at apical surface of the trophectoderm (arrowhead). (G) Similar section of a Cdx2 mutant blastocyst
from the same litter as shown in panel F. Apical aPKC is still detectable (arrowhead).
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E). This observation was somewhat unexpected since outside
cells are known to be polarized at 16- and 32-cell stages
(Johnson and McConnell, 2004). Thus, aPKC localization does
not appear to correlate with cell polarity at these stages. None-
theless, by the blastocyst stage, apical aPKC was enhanced in
the trophectoderm (for example, Fig. 3F), as previously reported
(Plusa et al., 2005).
To understand the temporal relationship between Cdx2
expression and aPKC localization, we examined Cdx2 expres-
sion and aPKC localization in individual embryos around the 8-
cell stage. At the 8-cell stage, nuclear Cdx2 was detectable in the
majority of embryos with apical aPKC (7 of 10 embryos).
However, in some embryos, apical aPKC was observed in em-bryos lacking detectable nuclear Cdx2 (3 of 10 embryos). In
contrast, we observed no embryos with nuclear Cdx2 and with
unlocalized aPKC (0 of 10 embryos). These observations
suggest that aPKC localization can precede nuclear Cdx2, sug-
gesting Cdx2 is temporally downstream of aPKC localization.
To functionally exclude the possibility that Cdx2 is required
for localization of aPKC, we examined the localization of aPKC
in Cdx2 mutants. In non-mutant littermates at the blastocyst
stage, aPKC was enriched on the apical surface of the trophec-
toderm (30 non-mutants, Fig. 3F). In Cdx2 mutant blastocysts,
aPKC localization was unaffected (6 mutants, Fig. 3G). Thus
aPKC localization is independent of the activity of zygotic
Cdx2, strongly suggesting that cell polarization is independent
of zygotic Cdx2.
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Our observations thus far suggested that Cdx2 expression
begins as early as the 8-cell stage, but it was unclear whether
trophectoderm fate follows this temporal trend. We therefore
examined another trophectoderm marker, the cytokeratin
intermediate filament Krt8 (EndoA), recognized by the anti-
body Troma-1 (Brulet and Jacob, 1982; Oshima et al., 1983), a
commonly used marker of differentiated trophectoderm. We
began by characterizing the dynamics of Krt8 expression in
early embryos on a population level. Krt8 was initially unlo-
calized, appearing diffuse throughout the cell at the 8-cell stage
in the majority of embryos (Figs. 4A, E). Between eight and 16-
cell stages, we detected Krt8 in filament-like structures that
localized to the apical cell surface in most embryos (Figs. 4B,
E). Krt8 was detected at the entire cell membrane of all cellsFig. 4. Localization of Krt8 during preimplantation development. (A) Confocal imag
(B) Example of an embryo with apically localized Krt8. (C) Example of an embryo
position within embryo. (D) Example of an embryo with reduced Krt8 in inside cell
numbers of embryos analyzed for each stage are indicated (n). (F) Projected confocal
(bracket demarcates cells with lower levels of both). (G) Projected confocal z-series o
to have lower levels of Krt8 (asterisk).around 17–25 cell stages (Figs. 4C, E), similar to the pattern
observed for aPKC at this stage. However, unlike aPKC, Krt8
appeared weaker in inside cells from 26–34 cell stages (Figs.
4D, E). These observations are consistent with a previous report
(Chisholm and Houliston, 1987), and suggest that while Krt8
eventually becomes patterned across the inside/outside axis of
the embryo, its initial apical localization appears to occur after
the onset of Cdx2 expression. To confirm this, we next exam-
ined embryos costained with Cdx2 and Krt8.
Simultaneous examination of Krt8 localization and Cdx2
expression in individual embryos also suggested that changes
in Cdx2 expression precede changes in Krt8, both initially and
at later stages. At the 8-cell stage we observed no embryos
with apically localized Krt8 and without detectable Cdx2 (0 of
20 embryos). Conversely, we did observe embryos with de-
tectable Cdx2 and without apically localized Krt8 (7 of 20es of an exemplary embryo with unlocalized Krt8 (stage and markers indicated).
with membrane-localized Krt8. Note Krt8 is detectable in all cells, regardless of
s (asterisks). (E) Summary of Krt8 distribution during early development. Total
z-series images of a 14-cell embryo in which Cdx2 and Krt8 levels are correlated
f the 33-cell embryo shown in panel D. Inside cells with lower Cdx2 also appear
621A. Ralston, J. Rossant / Developmental Biology 313 (2008) 614–629embryos). Thus detection of initial Cdx2 expression usually
precedes detection of Krt8 filaments. Interestingly, in a mosaic
14-cell embryo, Cdx2 and Krt8 were detectable largely in the
same subset of cells (Fig. 4F). At later stages (26 to 34 cells),
all embryos with reduced Krt8 in inside cells also had lower
levels of Cdx2 in those cells (n=14 embryos, Fig. 4G). How-
ever, some inside cells of these embryos had lower levels of
Cdx2, but Krt8 was still membrane-localized (11 of 14 em-
bryos, not shown). We conclude from these observations that
Krt8 is patterned across the inside/outside axis of the embryo
prior to blastocyst formation, but the timing of the Krt8 pat-
terning lags behind that of Cdx2 patterning. These observa-
tions raised the possibility that Cdx2 regulates Krt8 expression
or localization.Fig. 5. Cdx2 is not required for Krt8 localization, but is required for expression of high
(E3.5) derived from Cdx2 heterozygous intercross showing Cdx2 expression in th
(arrowhead), and merged Krt8/nuclear stain images. (B) Confocal section of a Cdx
showing the absence of zygotic Cdx2, reduced, but membrane localized Krt8 (arro
mutant, 16-cell embryo derived from Cdx2 heterozygous intercross showing Cdx2 ex
images. (D) Confocal section of a 16-cell Cdx2 mutant, collected at the same z-positi
reduced, but apically localized Krt8 (arrowhead), and merged Krt8/nuclear stain imaWe next examined the functional requirement for Cdx2 in
Krt8 expression and localization, by examining Krt8 in Cdx2
mutants at the blastocyst stage. In non-mutant blastocysts at
embryonic day 3.5 (E3.5), Krt8 was localized to the entire
membrane of trophectoderm cells, but not in inner cell mass
cells (n=25, Fig. 5A). In Cdx2 mutant blastocysts, Krt8 levels
appeared greatly reduced (n=9, Fig. 5B). Interestingly, how-
ever, Krt8 localization was not affected. A similar phenotype
was observed at the 16-cell stage as well (n=1 mutant, 11 non-
mutant, Figs. 5C, D). Thus Cdx2 is required for expression of
high levels of Krt8, but it is not required for Krt8 localization.
Patterned expression of Cdx2 and localization of Krt8 must
therefore be regulated in parallel by other sources of spatial
information in the embryo.levels of Krt8 in the blastocyst. (A) Confocal section of a non-mutant blastocyst
e trophectoderm, Krt8 enrichment in the cell membrane of the trophectoderm
2 mutant, collected at the same z-position as for littermate shown in panel A,
whead), and merged Krt8/nuclear stain images. (C) Confocal section of a non-
pression in outside cells, apical Krt8 (arrowhead), and merged Krt8/nuclear stain
on as for the littermate shown in panel C, showing the absence of zygotic Cdx2,
ges.
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Although localization of both aPKC and Krt8 is normal in
the absence of Cdx2, trophectoderm fate is not (Strumpf et al.,
2005), suggesting that cell polarity alone is not sufficient to
drive cell fate. In addition to aberrant expression of the inner
cell mass markers Oct4 and Nanog in the trophectoderm of
Cdx2 mutant blastocysts, we showed evidence of reduced ex-
pression of the trophectoderm gene Eomes by RT-PCR analysis
(ibid). Although Eomes is thought to be a trophectoderm-
expressed gene (Hancock et al., 1999; Kwon and Hadjantonakis,
2007; Russ et al., 2000), an antibody against Xenopus Eomes
detected ubiquitous nuclear Eomes throughout preimplantation
development (McConnell et al., 2005). To determine whether
loss of Cdx2 leads to reduction of Eomes in the trophectoderm,
we began by examining Eomes protein localization during pre-Fig. 6. Cdx2 is required for expression of Eomes in the trophectoderm. (A) Three ima
and Cdx2 alone. (B) Three images of a blastocyst (E3.5) showing Eomes alone, Eome
(C) Two images of an E4.5 blastocyst showing Eomes alone and Eomes merged with n
have different cell morphologies. Position of the inner cell mass (ICM) is also indicate
extraembryonic ectoderm (bracket), visceral endoderm (asterisk) and primitive streak
of Cdx2, loss of nuclear Eomes, and nuclear stain.implantation development using an antibody that has been
shown to specifically recognize mouse Eomes protein at later
developmental stages (Englund et al., 2005).
Using this antibody, we were unable to detect Eomes in
nuclei of 16–19 cell embryos, while Cdx2 was detected in this
group (n=6, Fig. 6A). At the blastocyst stage, however, nuclear
Eomes was detected exclusively in the trophectoderm (n=12,
Fig. 6B). Trophectoderm expression of Eomes persisted at the
implantation stage, embryonic day 4.5 (E4.5) (Fig. 6C), where it
was detectable in nuclei of the polar trophectoderm (6 of 6
embryos). Interestingly, Eomes appeared downregulated in the
mural trophectoderm of a minority of embryos (2 of 6 embryos),
while Cdx2 was downregulated in a larger proportion of these
embryos (4 of 6 embryos). At E6.5 Eomes continued to be
detected in the extraembryonic ectoderm portion of the tro-
phoblast lineage (n=3, Fig. 6D). Notably, Eomes protein wasges of a 16-cell embryo showing Eomes alone, Eomes merged with nuclear stain,
s merged with nuclear stain, and Cdx2 alone, marking cells of the trophectoderm.
uclear stain. Note Eomes in polar (pTE) and mural (mTE) trophectoderm, which
d. (D) Confocal cross-section of an E6.5 embryo with nuclear Eomes in proximal
(arrowhead). (E) Three images of a Cdx2mutant blastocyst (E3.5) showing loss
Fig. 7. Developmental potential of Cdx2 mutant cells in chimeric embryos. (A) Overview of strategy for examining lineage contribution of Cdx2 mutant cells in chimeric embryos. (B) Z-series projections of nuclear
stain, EGFP, and Cdx2 channels of a chimera containing EGFP-negative, non-mutant cells. Position of the inner cell mass (ICM) is indicated. (B′) Confocal cross-section of same embryo shown in panel B, with all three
channels merged and limit of the boundary between EGFP-positive and EGFP-negative cells indicated by white lines. Cdx2-positive cells appear purple. (C) Z-series projections of nuclear, EGFP, and Cdx2 channels of a
mutant chimera, with inner cell mass indicated. EGFP-negative trophectoderm cells are Cdx2-negative. (C′) Merged confocal cross-section of the embryo shown in panel C, with clonal boundary indicated, showing
EGFP label coincides with Cdx2-positive cells (purple). (D) Average lineage contribution of each population (indicated), expressed as a ratio of inner cell mass to trophectoderm cell numbers. For each chimera, the total
number of cells comprising each population (mutant or non-mutant and EGFP-expressing) was determined by counting DRAQ5-positive nuclei in each confocal cross-section. Values were then averaged, and error bars
show associated standard deviations (7 mutant chimeras and 31 non-mutants). No significant difference was detected among these groups (pN 0.05, ANOVA test).
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Table 2
Average lineage contributions in chimeric embryos
Mutant chimeras
(n=7)
Non-mutant chimeras
(n=30)
Total cells 112±21 108±17
ICM cells 28±8 25±7
TE cells 84±15 83±14
EGFP-neg cells 54±18 44±11
EGFP-neg ICM 14±5 9±7
EGFP-neg TE 40±15 34±9
EGFP-pos cells 58±7 65±15
EGFP-pos ICM 13±4 16±8
EGFP-pos TE 44±5 49±12
For each chimera, total cell number was determined by counting Draq5-positive
nuclei in optical sections of a confocal z-series. Contribution to inner cell mass
(ICM) or trophectoderm (TE) lineages was assigned on the basis of topological
position. Next, nuclei were assigned to EGFP-positive or -negative groups by
examining EGFP expression. Finally, genotype of non-EGFP expressing cells
(mutant or non-mutant) was determined by examining Cdx2 expression. Values
were averaged and are expressed±standard deviations.
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primitive streak, consistent with its gene expression pattern at
this stage (Ciruna and Rossant, 1999; Hancock et al., 1999;
Kwon and Hadjantonakis, 2007). These data therefore suggest
that Eomes is coexpressed with Cdx2 in the trophectoderm,
although the onset and eventual downregulation of Eomes in the
mural trophectoderm appear to lag behind Cdx2.
To investigate the requirement for Cdx2 in Eomes expres-
sion, we next examined the expression of Eomes in Cdx2
mutants using this same antibody. Strikingly, Eomes was not
detected in trophectoderm nuclei in Cdx2 mutant blastocysts
(n=6, Fig. 6E), while Eomes was unaffected in non-mutant
littermates (n=13, not shown). These results suggest that Cdx2
is required for expression of Eomes in the trophectoderm. We
conclude that Cdx2 mutant trophectoderm appears to lose
trophectoderm character in addition to acquiring inner cell mass
character.
Cdx2 mutant cells contribute to trophectoderm in chimeric
blastocysts
The observation that loss of zygotic Cdx2 leads trophecto-
derm to adopt inner cell mass gene expression led us to ask
whether Cdx2 mutant trophectoderm is functionally inner cell
mass and would preferentially contribute to inner cell mass in a
competitive assay. To test this hypothesis, we generated chi-
meric blastocysts containing wild type, EGFP-expressing cellsFig. 8. Cdx2 is required cell-autonomously for regulation of Oct4, Nanog, and Eomes
showing Oct4, merged Oct4/Cdx2, and merged Oct4/EGFP (channels indicated). No
negative cells. (B) Confocal section of a Cdx2mutant chimera showing elevated Nano
reduced Nanog in some cells of the inner cell mass, likely representing primitive endo
B, showing intermingling between EGFP-labeled and unlabeled cells in the trophec
negative cells). (D) Two images of a different Cdx2mutant chimera with a rare 1-cell p
Cdx2 mutant chimera showing loss of nuclear Eomes in EGFP-negative Cdx2-negati
showing Oct4, Cdx2, and merged EGFP and Oct4 images (channels indicated). Not
trophectoderm, and Cdx2 levels are uniform between EGFP-labeled and unlabeled ce
elevated in the inner cell mass and uniformly low between EGFP-labeled and unlabe
that nuclear Eomes is detectable throughout the trophectoderm.and unlabeled cells derived from embryos of Cdx2 mutant lit-
ters (Fig. 7A). In these chimeric blastocysts, cells derived from
Cdx2mutant litters lack EGFP expression, and can be identified
as Cdx2 mutant or non-mutant on the basis of immunofluor-
escent staining for Cdx2. To facilitate cell counting, we also
stained these embryos with the nuclear marker DRAQ5. We
found no significant differences in total cell number, or in
relative inner cell mass or trophectoderm cell number, between
chimeras containing mutant or non-mutant tissue, indicating
that early development was not compromised by this manipula-
tion. Moreover, Cdx2 mutant cells did not appear to have a
disadvantage in contributing to total cell number in chimeric
blastocysts (Table 2).
We first examined the ability of Cdx2 mutant cells to con-
tribute to trophectoderm in chimeric embryos. Non-mutant,
EGFP-negative cells contributed to both inner cell mass and
trophectoderm in all chimeras examined (n=30, Fig. 7B). Sur-
prisingly, Cdx2 mutant cells also contributed to both inner cell
mass and trophectoderm in all chimeras examined (n=7, Fig.
7C). These observations suggest that Cdx2 is not strictly
required for the initial inner cell mass/trophectoderm lineage
decision.
We next examined whether loss of Cdx2 could bias cells to
contribute disproportionately to inner cell mass. For each cell
population, we compared its contribution to inner cell mass
relative to its contribution to trophectoderm. We found no sig-
nificant difference in the contribution of mutant cells to inner
cell mass over trophectoderm, when compared with similar
ratios for either non-mutant or EGFP-expressing populations
(Fig. 7D). Thus Cdx2 mutant cells do not have an enhanced
tendency to contribute to inner cell mass over trophectoderm,
even in competition with wild type cells. These results suggest
that factors upstream of Cdx2 govern allocation of cells to inner
cell mass or trophectoderm.
Cdx2 regulates trophectoderm fate cell-autonomously
Our observation that Cdx2 mutant cells contribute to tro-
phectoderm at wild type ratios in chimeras raised the
possibility that the Cdx2 mutant phenotype is non-cell-
autonomously rescued by neighboring, wild type tissue. This
could result, for example, if intercellular signaling downstream
of Cdx2 helped regulate expression of Cdx2 targets in the
trophectoderm. We therefore examined the expression of Oct4,
Nanog, and Eomes in Cdx2 mutant trophectoderm cells in
chimeric blastocysts.expression in the trophectoderm. (A) Confocal section of a Cdx2mutant chimera
te that elevated Oct4 in the trophectoderm coincides with Cdx2-negative EGFP-
g in the trophectoderm coincides with Cdx2-negative EGFP-negative cells. Note
derm differentiation. (C) A different section of the same embryo shown in panel
toderm and cell-autonomous upregulation of Nanog in EGFP-negative (Cdx2-
atch of mutant trophectoderm with upregulated Nanog. (E) Confocal section of a
ve cells within the trophectoderm. (F) Confocal section of a non-mutant chimera
e Oct4 levels are elevated in the inner cell mass, but are uniformly lower in the
lls. (G) Confocal section of a non-mutant chimera showing that Nanog levels are
led trophectoderm cells. (H) Confocal section of a non-mutant embryo showing
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626 A. Ralston, J. Rossant / Developmental Biology 313 (2008) 614–629In chimeras containing Cdx2 mutant cells, Oct4 levels were
expressed at inner cell mass levels in Cdx2 mutant trophecto-
derm cells in all embryos examined (n=3 mutant chimeras, Fig.
8A). In contrast, Oct4 levels were low in neighboring, wild
type, EGFP-labeled trophectoderm cells. These observations
indicate that Cdx2 is cell-autonomously required for repression
of Oct4 in the trophectoderm. In chimeras containing non-mu-
tant cells, Oct4 levels were uniformly low in both EGFP-labeled
and unlabeled trophectoderm cells in most chimeras (10/14 non-
mutant chimeras, Fig. 8F). In a minority of non-mutant chime-
ras, Oct4 was elevated in the EGFP-negative trophectoderm (4/
14 non-mutant chimeras, not shown). We suspect that these
cells were heterozygous for the Cdx2 null allele and thus
exhibited intermediate repression of Oct4, as we have observed
in Cdx2 heterozygous blastocysts (not shown). Nonetheless, the
effect was cell-autonomous. These observations strongly sug-
gest that Cdx2 is required cell-autonomously to repress Oct4 in
the trophectoderm.
Next, we examined levels of Nanog in chimeric embryos. In
chimeras containing Cdx2 mutant cells, Nanog was cell-auto-
nomously elevated in Cdx2 mutant trophectoderm cells (n=4
mutant chimeras, Fig. 8B). Nanog derepression was strictly cell-
autonomous, even in very small groups of cells (Figs. 8C, D).
Nanog was downregulated in some cells of the inner cell mass
(for example, Fig. 8B). However, this is likely to be due to
repression of Nanog in presumptive primitive endoderm cells
that occurs around this stage (Chazaud et al., 2006) rather than a
consequence of genetic manipulation. In non-mutant trophecto-
derm cells, Nanog levels were uniformly low between unlabeled
and EGFP-labeled cells in the vast majority of chimeras (20/21
chimeras, Fig. 8G). We conclude from these observations that
Cdx2 acts cell-autonomously to repress expression of two key
inner cell mass genes Oct4 and Nanog in the trophectoderm.
Finally, we examined Eomes expression in chimeras. In
chimeras containing Cdx2 mutant cells, nuclear Eomes was not
detected in Cdx2 mutant trophectoderm cells. In contrast,
nuclear Eomes was detected in neighboring, wild type, EGFP-
expressing tissue (3/3 mutant chimeras, Fig. 8E). Thus, like
other lineage markers, Eomes is also regulated in a cell-
autonomous manner. In chimeras containing non-mutant cells,
nuclear Eomes was detected in all trophectoderm cells (n=20
non-mutant chimeras, Fig. 8H). Eomes levels appeared slightly
weaker in EGFP-negative trophectoderm cells in a minority of
chimeras (5/20 non-mutant chimeras, not shown), possibly due
to incorporation of cells heterozygous for the null Cdx2 allele,
as discussed above.
Together, these observations suggest that Cdx2 promotes
trophectoderm and represses inner cell mass genes cell-
autonomously, and rules out the likelihood that Cdx2 regulates
these targets via extracellular signaling among trophectoderm
cells. Thus despite normal contribution to tissue that is
morphologically trophectoderm-like, Cdx2 mutant cells exhibit
defects in trophectoderm gene expression in chimeric
blastocysts. These observations are consistent with the
proposal that factors upstream of Cdx2 function regulate
allocation to inside and outside populations during blastocyst
formation.Discussion
Here, we have examined the regulation and role of Cdx2 in
preimplantation mouse development and show that cell
polarity and position are regulated independently of Cdx2.
This suggests that, although Cdx2 is required for regulation of
inner cell mass and trophectoderm gene expression, factors
regulating trophectoderm morphogenesis might regulate Cdx2
itself. Our evidence suggests that Cdx2 is initially ubiquitously
expressed, although there is some variation among embryos
and within cells of individual embryos. This mosaicism, which
appears unpatterned initially, could be explained in several
ways. First, random mosaic expression could be converted to
positionally appropriate expression by physical sorting of cells
lacking Cdx2 into a more internal position, giving rise to
patterned Cdx2. This model would imply differences in the
developmental potential of a subset of cells, as has been pro-
posed to exist at the 4-cell stage (Piotrowska-Nitsche et al.,
2005). However, our analyses of chimeras containing cells
lacking Cdx2 suggest that Cdx2 is unlikely to control cell
position within the embryo since cells completely lacking
zygotic Cdx2 do not show a preference for inside position.
Moreover, Cdx2 is detected in all cells of some embryos, making
it difficult to apply a cell sorting-based mechanism. An
alternative, and more compelling explanation for the observed
initial mosaicism is that differences in maturation or cell cycle
status among individual cells leads to differences in the timing of
Cdx2 initiation. Thus initial mosaicism is likely to be a transient
state, wherein all cells of an embryo will eventually express
some level of Cdx2.
The processes or factors that regulate Cdx2 expression are
not yet clear. Two recent reports have provided evidence that the
TEAD4 transcription factor is required for initial Cdx2 expres-
sion during preimplantation development (Yagi et al., 2007;
Nishioka et al., in press). However, our analysis suggests that
soon after initiation of expression, Cdx2 levels are regulated
across the inside/outside axis of the embryo, with progressively
higher levels in outside cells, and low, but detectable levels in
inside cells (Fig. 9A). Lineage tracing experiments have
suggested that oriented cleavages at 8- and 16-cell stages give
rise to two polarized outside or one polarized outside and one
apolar inside cell (Fleming, 1987). A mechanism is therefore
required for both elevating Cdx2 in outside cells while lowering
Cdx2 in nascent inside cells. A compelling model is that
components of the cell polarization pathway contribute to
regulation of Cdx2, thereby coordinating gene regulation and
positional information. Consistent with this hypothesis, we
show that Cdx2 is downstream of cell polarization. Small
changes in Cdx2 level or activity conferred by cell position
could be further amplified or locked in through Cdx2
autoregulation, which has been observed in embryonic stem
cells during differentiation to trophoblast (Niwa et al., 2005), as
well as other cellular contexts (Niwa et al., 2005; Xu et al.,
1999). By later blastocyst stages, differences in Cdx2 levels in
trophectoderm and inner cell mass populations are so extreme as
to make it difficult to measure within the same embryo using
our methods. Importantly, Cdx2 is not required for early
Fig. 9. Models of early lineage specification. (A) Around the 8-cell stage, Cdx2 is expressed at low levels throughout the embryo. Levels increase during transition to the
16-cell stage, whereupon Cdx2 is elevated in outside cells and comparatively reduced in nascent inside cells. This trend continues to the 32-cell stage when Cdx2
becomes stably expressed at high levels in outside cells and further reduced during allocation of new inside cells. (B) Developmental strategies used during early lineage
specification in the mouse. During trophectoderm formation, cell polarization (green) may contribute to establishment of differences in Cdx2 levels between inside and
outside cell populations. Cdx2 acts within the protoepithelium to regulate expression of transcription factors important for reinforcing cell fates. During primitive
endoderm formation, differential expression of transcription factors in presumptive primitive endoderm and epiblast cells precedes sorting into distinct positions in the
late blastocyst.
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al., 2004), suggesting that Cdx2 is functionally unimportant in
the inner cell mass.
Our data suggest that continued elevation of Cdx2 in
outside cells eventually leads to positive regulation of
trophectoderm lineage markers, such as Eomes and Krt8.
However, the trophectoderm marker Krt8 is patterned in
parallel to Cdx2, and is thus likely to respond to similar inputs.
Cell polarization may initially regulate Cdx2 and Krt8
patterning, but Cdx2 appears to feed back onto cell polarity,
ensuring high levels of Krt8 expression in the trophectoderm.
This role is similar to the proposed role of Cdx2 inmaintenance of cell junctions in the trophectoderm (Strumpf
et al., 2005).
In addition to promoting trophectoderm fate, Cdx2 also
negatively regulates inner cell mass markers Oct4, and Nanog
(Strumpf et al., 2005). An interesting question for future studies
is whether Oct4, in turn, regulates Cdx2. While this relationship
has been observed in embryonic stem cells during differentiation
to trophoblast (Niwa et al., 2000), it has not been examined in the
embryo. Differences in Cdx2 expression levels precede changes
in Oct4 between inside and outside cells (Niwa et al., 2005;
Strumpf et al., 2005), suggesting that Oct4 is unlikely to regulate
initial changes in Cdx2 expression. Nonetheless, Oct4 null
628 A. Ralston, J. Rossant / Developmental Biology 313 (2008) 614–629embryos variably upregulate the trophectoderm marker Krt8 in
the inner cell mass (Nichols et al., 1998), suggesting Oct4 could
play a late role repressing Cdx2 in the inner cell mass.
Finally, our study highlights an important difference in
developmental strategies used during early lineage decisions in
the mouse. Our evidence suggests that cell position is deter-
mined independently of regulation of trophectoderm and inner
cell mass-expressed transcription factors. Interestingly, this re-
lationship appears to be reversed for the second lineage decision
during mouse development (Fig. 9B). Subdivision of inner cell
mass into epiblast and primitive endoderm lineages can first be
observed by differential expression of transcription factors
Nanog and Gata6 in an unpatterned manner throughout the
inner cell mass, prior to overt formation of distinct epiblast and
primitive endoderm layers (Chazaud et al., 2006). These cells
are thought to sort into their ultimate positions, thus placing
transcription factor regulation upstream of cell position. Like
Cdx2, Gata6 is sufficient to induce a lineage fate change in
embryonic stem cells, causing their differentiation to primitive
endoderm-like cells (Fujikura et al., 2002). Thus while early
lineage transcription factors are capable of altering cell fate and
associated morphological changes in embryonic stem cells,
their precise roles during lineage establishment appears to differ.
Note added in proof
During preparation of this manuscript, another group
reported variable onset of Cdx2 expression in cultured pre-
implantation embryos (Dietrich and Hiiragi, 2007), consistent
with our observations. Interestingly, Cdx2 variability did not
initially correlate with changes in the cell fate markers Oct4 or
Nanog, also suggesting other sources of patterning information
regulate lineage establishment.
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